Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Friesen

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Behaviour Research and Therapy|December 4, 2020
Wakefulness impairs selective consolidation of relevant trauma-associated memories resulting in more frequent intrusionsM R Sopp, E Friesen, S K Schäfer, et al.
Chemical Biology & Drug Design|January 25, 2012
Discovery of small molecule inhibitors that interact with γ-tubulinDouglas E Friesen, Khaled H Barakat, Valentyna Semenchenko, et al.
The Journal of Infectious Diseases|November 17, 2009
Pre- and postexposure use of human monoclonal antibody against H5N1 and H1N1 influenza virus in mice: viable alternative to oseltamivirWouter Koudstaal, Martin H Koldijk, Just P J Brakenhoff, et al.
JEMS : a Journal of Emergency Medical Services|January 28, 2015
A tale of three successful EMS systems. How coordinated "pit crew" procedures have helped improve cardiac arrest resuscitations in the fieldSabina Braithwaite, Jon E Friesen, Scott Hadley, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2014
Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle levelJason J Otterstrom, Boerries Brandenburg, Martin H Koldijk, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 16, 2000
Bioequivalence and interchangeability of narrow therapeutic range drugs. Canadian Society for Pharmaceutical Sciences discussionE Palylyk-Colwell, F Jamali, W Dryden, et al.
Scientific Reports|August 31, 2017
Response to Alternating Electric Fields of Tubulin Dimers and Microtubule Ensembles in Electrolytic SolutionsIara B Santelices, Douglas E Friesen, Clayton Bell, et al.
The Journal of Infectious Diseases|October 9, 2007
Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicans infectionAntonella Lupetti, Carlo P J M Brouwer, Sylvia J P Bogaards, et al.
Plos One|February 18, 2010
New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferretsRobert H E Friesen, Wouter Koudstaal, Martin H Koldijk, et al.
Plos One|December 19, 2013
Mechanisms of hemagglutinin targeted influenza virus neutralizationBoerries Brandenburg, Wouter Koudstaal, Jaap Goudsmit, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Behaviour Research and Therapy|December 4, 2020
Wakefulness impairs selective consolidation of relevant trauma-associated memories resulting in more frequent intrusionsM R Sopp, E Friesen, S K Schäfer, et al.
Chemical Biology & Drug Design|January 25, 2012
Discovery of small molecule inhibitors that interact with γ-tubulinDouglas E Friesen, Khaled H Barakat, Valentyna Semenchenko, et al.
The Journal of Infectious Diseases|November 17, 2009
Pre- and postexposure use of human monoclonal antibody against H5N1 and H1N1 influenza virus in mice: viable alternative to oseltamivirWouter Koudstaal, Martin H Koldijk, Just P J Brakenhoff, et al.
JEMS : a Journal of Emergency Medical Services|January 28, 2015
A tale of three successful EMS systems. How coordinated "pit crew" procedures have helped improve cardiac arrest resuscitations in the fieldSabina Braithwaite, Jon E Friesen, Scott Hadley, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2014
Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle levelJason J Otterstrom, Boerries Brandenburg, Martin H Koldijk, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 16, 2000
Bioequivalence and interchangeability of narrow therapeutic range drugs. Canadian Society for Pharmaceutical Sciences discussionE Palylyk-Colwell, F Jamali, W Dryden, et al.
Scientific Reports|August 31, 2017
Response to Alternating Electric Fields of Tubulin Dimers and Microtubule Ensembles in Electrolytic SolutionsIara B Santelices, Douglas E Friesen, Clayton Bell, et al.
The Journal of Infectious Diseases|October 9, 2007
Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicans infectionAntonella Lupetti, Carlo P J M Brouwer, Sylvia J P Bogaards, et al.
Plos One|February 18, 2010
New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferretsRobert H E Friesen, Wouter Koudstaal, Martin H Koldijk, et al.
Plos One|December 19, 2013
Mechanisms of hemagglutinin targeted influenza virus neutralizationBoerries Brandenburg, Wouter Koudstaal, Jaap Goudsmit, et al.
Pageof 4